J0695 is a valid 2023 HCPCS Code that could be used to indicate Injection, ceftolozane 50 mg and tazobactam 25 mg for reimbursement purposes.
J0695 belongs to Medical Care Type of Service and has been in effect since Jan 01, 2016.
Inj ceftolozane tazobactam
J0695 code information
| HCPCS code: | J0695 |
| Description: | INJECTION, CEFTOLOZANE 50 MG AND TAZOBACTAM 25 MG |
| Effective Date: | Jan 01, 2016 |
| Added Date: | Jan 01, 2016 |
| Termination Date: | HCPCS J0695 was terminated on Nov 30, -0001 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | O1E - OTHER DRUGS |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
1 - MEDICAL CARE
P - LUMP SUM PURCHASE OF DME, PROSTHETICS, ORTHOTICS
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to J0695